ICAM1 and gastric cancer: To further assess the pathological significance of tsNeu3/4 (CD54+ tsNeus), we processed data from 72 GC patients by extracting nine available clinical factors in three categories, that is, the clinical background (age, gender), immunohistochemistry data (Lauren classification, differentiation, lymphatic invasion), and the cancer stage information (tumor size, lymph node metastasis, distant metastasis, tumor stage).